AVECTAS

Welcome to the Brand page for “AVECTAS”, which is offered here for Scientific apparatus and instruments, scientific apparatus and instruments for the transfer of biological molecules into living cells; measuring apparatus and instruments, pressure measuring apparatus; probes for scientific purposes, ultrasound probes, not for medical use; bioassay apparatus, pressure measuring apparatus for use in bioassay techniques other than medical; replacement parts and fittings for the aforesaid goods;pharmaceutical preparations for the treatment of immuno oncological disorders, cancer, diabetes, respiratory, heart, neurological and auto immune disorders; stem cells for medical purposes; living cells for medical use;stem cells for research purposes;the wording avectas has no meaning in a foreign language.;surgical apparatus and instruments; medical apparatus and instruments for delivery of macro molecules to the mouth, nose, airway, lungs; veterinary apparatus and instruments, catheter for veterinary purposes; medical and surgical probes; probes for medical use and medical diagnostic purposes; medical heartbeat measuring apparatus for use in bioassay techniques; replacement parts and fittings for the aforesaid goods; measuring apparatus and instruments, heartbeat measuring apparatus;scientific and technological services, research and design in the field of pharmaceutics, tissue engineering and regenerative medicine; analysis of industrial fluids and scientific research services; medical and scientific research; pharmaceutical research and development; and clinical testing, conducting clinical trials for others in the field of pharmaceutical preparations, drugs, cell therapy, gene therapy and cancer therapy; development of probes, reagents and bioassays for industrial and scientific purposes; advisory, consultancy and information services relating to the provision of the aforesaid;.

Its status is currently believed to be active. Its class is unavailable. “AVECTAS” is believed to be currently owned by “AVECTAS LIMITED”.